Vimarsana
Biggest News Aggregation in the World

Anotechnology News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Anotechnology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Anotechnology Today - Breaking & Trending Today

Efficient intranasal delivery of agomelatine via micellar encapsulation - Vimarsana News

Efficient intranasal delivery of agomelatine via micellar encapsulation

Announcing a new publication for Acta Materia Medica journal. Agomelatine (AGO) is an antidepressant with limited clinical application due to its low bioavailability caused by poor water solubility, severe hepatic degradation, and poor intracerebral distribution.

Nanotechnology Offers Hope with Oral Insulin Innovation, Revolutionizing Diabetes Treatment - Vimarsana News

Nanotechnology Offers Hope with Oral Insulin Innovation, Revolutionizing Diabetes Treatment

Designed to be consumed like any other tablet, the oral insulin pill has undergone rigorous testing on various animal models, including mice, rats, and baboons.

Smart labs for bespoke synthesis of nanomaterials are emerging - Vimarsana News

Smart labs for bespoke synthesis of nanomaterials are emerging

The Korea Institute of Science and Technology (KIST) announced that Dr. Sang Soo, Han and Dr. Donghun, Kim of the Computational Science Research Center and Prof

New vaccine technology provides protection against broad range of coronaviruses in mice - Vimarsana News

New vaccine technology provides protection against broad range of coronaviruses in mice

Researchers have developed a new vaccine technology that has been shown in mice to provide protection against a broad range of coronaviruses with potential for future disease outbreaks - including ones we don't even know about.

Global Nano Robotics Market Projected to Surge to US$ 19.86 - Vimarsana News

Global Nano Robotics Market Projected to Surge to US$ 19.86

Dublin, May 03, 2024 (GLOBE NEWSWIRE) -- The